Clinical Trial Update: Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF)

View source ↗

Summary

This clinical trial evaluates the real-world benefit and risk of new oral anticoagulants and vitamin K antagonists in patients aged 75 years and older with non-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-valvular Atrial Fibrillation

Drugs mentioned

• Apixaban (apixaban)
• Dabigatran (Dabigatran etexilate)
• Edoxaban (edoxaban)
• Rivaroxaban (rivaroxaban)
• Warfarin (warfarin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Non Valvular Atrial Fibrillation (nv AF) | Status: UNKNOWN